Keyphrases
Peruvian
100%
Resistance Level
100%
Microorganisms
100%
ESKAPE
100%
Evolution of Antimicrobial Resistance
100%
Intensive Care Unit
50%
Enterococcus Faecium
50%
Antibiotic Resistance
50%
Baumannii
50%
Staphylococcus Aureus
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Klebsiella Pneumoniae (K. pneumoniae)
33%
ESKAPE Group
33%
Peru
16%
Lima
16%
Antimicrobial Resistance
16%
Clinical Samples
16%
Antimicrobial Susceptibility
16%
Antimicrobial
16%
Extensively Drug-resistant
16%
Carbapenems
16%
Vancomycin
16%
Extended-spectrum-lactamase
16%
Cephalosporins
16%
Hospital-acquired Infection
16%
Sulbactam
16%
Enhanced Resistance
16%
Automatic Method
16%
Severe Infection
16%
Amoxicillin
16%
Acinetobacter Baumannii (A. baumannii)
16%
Bacterial Identification
16%
Enterobacter
16%
Long-time Analysis
16%
Susceptibility Level
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Resistance
100%
Antibiotic Resistance
100%
Microorganism
100%
Pseudomonas aeruginosa
33%
Staphylococcus Aureus
33%
Antiinfective Agent
33%
Infection
16%
Cephalosporin Derivative
16%
Carbapenem Derivative
16%
Acinetobacter Baumannii
16%
Penicillinase
16%
Hospital Infection
16%
Enterobacter
16%
Sulbactam
16%
Klebsiella pneumoniae
16%
Amoxicillin
16%
Vancomycin
16%
Enterococcus faecium
16%
Immunology and Microbiology
Antimicrobial Resistance
100%
Microorganism
100%
Staphylococcus Aureus
33%
Pseudomonas aeruginosa
33%
Antibiotic Sensitivity
16%
Enterococcus faecium
16%
Enterobacter
16%
Klebsiella pneumoniae
16%
Acinetobacter Baumannii
16%
Bacterium Identification
16%